Health
Sanofi’s mRNA COVID-19 vaccine candidate not ready this year, CEO says – Reuters
A COVID-19 vaccine candidate developed by Sanofi and U.S. group Translate Bio “will not be ready this year,” the French drugmaker’s chief executive told Le Journal…
By Reuters Staff
PARIS (Reuters) – A COVID-19 vaccine candidate developed by Sanofi and U.S. group Translate Bio will not be ready this year, the French drugmakers chief executive told Le Journal du Dimanche newspaper.
FILE PHOTO: Paul Hudson, Chief Executive Officer of Sanofi, delivers a speech after a visit at the French drugmaker’s vaccine unit Sanofi Pasteur plant in Marcy-l’Etoile, near Lyon, France, June 16, 2020. REUTERS/Gonzalo Fuentes/Pool
Clinical trials of this vaccine, which will be…
-
Business20 hours agoThis ASX 200 healthcare stock crashed 14% to 4-year low. Here’s what happened
-
Noosa News17 hours agoBob Katter threatens to punch Nine reporter during ant-immigration press conference
-
Business16 hours agoDicker Data rides the AI trend to double digit growth
-
Business19 hours agoForget CBA shares, this ASX 200 financials stock could be a better buy